The metabolism of 17 alpha‐ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.
Open Access
- 1 April 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 23 (4) , 447-453
- https://doi.org/10.1111/j.1365-2125.1987.tb03074.x
Abstract
The metabolism of 17 alpha-ethinyloestradiol (EE2) to catechol and reactive metabolites by human liver microsomes was investigated. 2- Hydroxyethinyloestradiol (2-OHEE2) was either the sole or principal metabolite. Small amounts of 6-hydroxyethinyloestradiol and 16- hydroxyethinyloestradiol were produced by some of the livers. EE2 (10 microM) underwent substantial (5-20% of incubated drug), though highly variable, NADPH-dependent metabolism to material irreversibly bound to microsomal protein. 2-OHEE2 appeared to be the pro-reactive metabolite. The maximum EE2 2-hydroxylase activity was 0.67 nmol min-1 mg-1 microsomal protein, with a Km value of 8.6 microM. Oestradiol, which is mainly hydroxylated to 2-hydroxyoestradiol, was the most potent inhibitor of hydroxylase activity and exhibited competitive inhibition. Progesterone, which undergoes 2-hydroxylation to a minor extent was also a competitive inhibitor, whereas cholesterol and cortisol did not have any appreciable inhibitory effect. Primaquine was the most potent non-steroidal inhibitor but was non-competitive. Other non-steroidal compounds investigated, e.g. antipyrine, did not show any significant effect on EE2 2-hydroxylation. The results of this study suggest that EE2 2-hydroxylation is metabolised by a form(s) of cytochrome P-450 which has affinity for endogenous steroids.This publication has 35 references indexed in Scilit:
- Inhibition of estrogen 2-hydroxylaseThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Estrogen 1,2-epoxides or estrogen quinones/semiquinonesBiochemical and Biophysical Research Communications, 1985
- Human cytochromes P-450Xenobiotica, 1984
- Drug protein conjugates—III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiolsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Interindividual Variations in Drug DispositionClinical Pharmacokinetics, 1983
- The biotransformation of 17α-ethynyl[3H]estradiol in the rat: Irreversible binding and biliary metabolitesXenobiotica, 1982
- The catechol estrogensJournal of Steroid Biochemistry, 1981
- Cytochrome P-450 Monooxygenase Activities in Human and Rat Liver MicrosomesEuropean Journal of Biochemistry, 1981
- Effects of Insecticide Synergists on Microsomal Oxidation of Estradiol and Ethynylestradiol and on Microsomal Drug MetabolismXenobiotica, 1976
- Irreversile binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinasJournal of Steroid Biochemistry, 1974